{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:57:23Z","timestamp":1771847843255,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:00:00Z","timestamp":1539734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2012M3A9C4048759"],"award-info":[{"award-number":["NRF-2012M3A9C4048759"]}],"id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recently, anoctamin1 (ANO1), a calcium-activated chloride channel, has been considered an important drug target, due to its involvement in various physiological functions, as well as its possibility for treatment of cancer, pain, diarrhea, hypertension, and asthma. Although several ANO1 inhibitors have been discovered by high-throughput screening, a discovery of new ANO1 inhibitors is still in the early phase, in terms of their potency and specificity. Moreover, there is no computational model to be able to identify a novel lead candidate of ANO1 inhibitor. Therefore, three-dimensional quantitative structure-activity relationship (3D-QSAR) pharmacophore modeling approach was employed for identifying the essential chemical features to be required in the inhibition of ANO1. The pharmacophore hypothesis 2 (Hypo2) was selected as the best model based on the highest correlation coefficient of prediction on the test set (0.909). Hypo2 comprised a hydrogen bond acceptor, a hydrogen bond donor, a hydrophobic, and a ring aromatic feature with good statistics of the total cost (73.604), the correlation coefficient of the training set (0.969), and the root-mean-square deviation (RMSD) value (0.946). Hypo2 was well assessed by the test set, Fischer randomization, and leave-one-out methods. Virtual screening of the ZINC database with Hypo2 retrieved the 580 drug-like candidates with good potency and ADMET properties. Finally, two compounds were selected as novel lead candidates of ANO1 inhibitor, based on the molecular docking score and the interaction analysis. In this study, the best pharmacophore model, Hypo2, with notable predictive ability was successfully generated, and two potential leads of ANO1 inhibitors were identified. We believe that these compounds and the 3D-QSAR pharmacophore model could contribute to discovering novel and potent ANO1 inhibitors in the future.<\/jats:p>","DOI":"10.3390\/ijms19103204","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T10:22:54Z","timestamp":1539771774000},"page":"3204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-5266","authenticated-orcid":false,"given":"Yoon Hyeok","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Bio and Brain engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-6546","authenticated-orcid":false,"given":"Gwan-Su","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Bio and Brain engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/science.1163518","article-title":"TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity","volume":"322","author":"Caputo","year":"2008","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.09.003","article-title":"Expression cloning of TMEM16A as a calcium-activated chloride channel subunit","volume":"134","author":"Schroeder","year":"2008","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nature07313","article-title":"TMEM16A confers receptor-activated calcium-dependent chloride conductance","volume":"455","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21413","DOI":"10.1073\/pnas.0911935106","article-title":"Studies on expression and function of the TMEM16A calcium-activated chloride channel","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/physrev.00039.2011","article-title":"Structure and function of TMEM16 proteins (anoctamins)","volume":"94","author":"Pedemonte","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00424-016-1790-0","article-title":"Cellular functions of TMEM16\/anoctamin","volume":"468","author":"Oh","year":"2016","journal-title":"Pflugers Arch."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","article-title":"Green fluorescent protein-based halide indicators with improved chloride and iodide affinities","volume":"499","author":"Galietta","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.107.043208","article-title":"Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel","volume":"73","author":"Namkung","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1074\/jbc.M110.175109","article-title":"TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells","volume":"286","author":"Namkung","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/mol.113.087502","article-title":"MONNA, a potent and selective blocker for transmembrane protein with unknown function 16\/anoctamin-1","volume":"84","author":"Oh","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16354","DOI":"10.1073\/pnas.1214596109","article-title":"Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Seo, Y., Lee, H.K., Park, J., Jeon, D.K., Jo, S., Jo, M., and Namkung, W. (2016). Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155771"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1096\/fj.10-160648","article-title":"Inhibition of Ca2+-activated Cl\u2212 channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea","volume":"24","author":"Namkung","year":"2010","journal-title":"FASEB J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yao, Z., Namkung, W., Ko, E.A., Park, J., Tradtrantip, L., and Verkman, A.S. (2012). Fractionation of a herbal antidiarrheal medicine reveals eugenol as an inhibitor of Ca2+-Activated Cl\u2212 channel TMEM16A. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038030"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Seo, Y., Ryu, K., Park, J., Jeon, D.K., Jo, S., Lee, H.K., and Namkung, W. (2017). Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174935"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/mol.109.061051","article-title":"Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels","volume":"77","author":"Tradtrantip","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1586\/egh.11.87","article-title":"Crofelemer for the treatment of secretory diarrhea","volume":"6","author":"Cottreau","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1242\/jcs.093260","article-title":"Ca2+-activated Cl\u2212 channels at a glance","volume":"125","author":"Berg","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev.physiol.67.032003.154341","article-title":"Calcium-activated chloride channels","volume":"67","author":"Hartzell","year":"2005","journal-title":"Annu. Rev. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22799","DOI":"10.3390\/molecules201219880","article-title":"Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases","volume":"20","author":"Kaserer","year":"2015","journal-title":"Molecules"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-12-S14-S4","article-title":"Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors","volume":"12","author":"John","year":"2011","journal-title":"BMC Bioinform."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1186\/1471-2105-12-S1-S28","article-title":"Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies","volume":"12","author":"John","year":"2011","journal-title":"BMC Bioinform."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Niu, M., Dong, F., Tang, S., Fida, G., Qin, J., Qiu, J., Liu, K., Gao, W., and Gu, Y. (2013). Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082360"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/aps.2014.34","article-title":"Tubulin inhibitors: Pharmacophore modeling, virtual screening and molecular docking","volume":"35","author":"Niu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/aps.2015.17","article-title":"Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling","volume":"36","author":"Kumar","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature25024","article-title":"Cryo-EM structures of the TMEM16A calcium-activated chloride channel","volume":"552","author":"Dang","year":"2017","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature24652","article-title":"Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM","volume":"552","author":"Paulino","year":"2017","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e26232","DOI":"10.7554\/eLife.26232","article-title":"Structural basis for anion conduction in the calcium-activated chloride channel TMEM16A","volume":"6","author":"Paulino","year":"2017","journal-title":"eLife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.bmc.2012.05.074","article-title":"Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3109\/14756366.2015.1135912","article-title":"Synthesis and evaluation of 5,6-disubstituted thiopyrimidine aryl aminothiazoles as inhibitors of the calcium-activated chloride channel TMEM16A\/Ano1","volume":"31","author":"Piechowicz","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/CIRCRESAHA.112.264440","article-title":"Explaining calcium-dependent gating of anoctamin-1 chloride channels requires a revised topology","volume":"110","author":"Yu","year":"2012","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e02772","DOI":"10.7554\/eLife.02772","article-title":"A comprehensive search for calcium binding sites critical for TMEM16A calcium-activated chloride channel activity","volume":"3","author":"Tien","year":"2014","journal-title":"eLife"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1085\/jgp.201611651","article-title":"Independent activation of distinct pores in dimeric TMEM16A channels","volume":"148","author":"Jeng","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1085\/jgp.201611650","article-title":"Independent activation of ion conduction pores in the double-barreled calcium-activated chloride channel TMEM16A","volume":"148","author":"Lim","year":"2016","journal-title":"J. Gen. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem Substance and Compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_38","unstructured":"Guner, O.F. (2000). HypoGen: An automated system for generating 3D predictive pharmacophore models. Pharmacophore Perception Development, and Use in Drug Design, International University Line."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(02)00004-2","article-title":"Prediction of intestinal permeability","volume":"54","author":"Egan","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1023\/B:JCAM.0000021834.50768.c6","article-title":"In silico models for the prediction of dose-dependent human hepatotoxicity","volume":"17","author":"Cheng","year":"2003","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1021\/jm020266b","article-title":"Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships","volume":"46","author":"Cheng","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci030283p","article-title":"Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition","volume":"43","author":"Susnow","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/jm0303195","article-title":"Classification of kinase inhibitors using a Bayesian model","volume":"47","author":"Xia","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/ci6004299","article-title":"Validation studies of the site-directed docking program LibDock","volume":"47","author":"Rao","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11029","DOI":"10.1074\/jbc.M114.549188","article-title":"Small molecule-facilitated degradation of ANO1 protein: A new targeting approach for anticancer therapeutics","volume":"289","author":"Bill","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:26:09Z","timestamp":1760196369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,17]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["ijms19103204"],"URL":"https:\/\/doi.org\/10.3390\/ijms19103204","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,17]]}}}